COVID-19 – Indonesia allows Sinopharm as heterologous vaccine
National

COVID-19 – Indonesia allows Sinopharm as heterologous vaccine

Jakarta (Indonesia Window) – Indonesia’s National Agency of Drug and Food Control (BPOM) has issued a permit to use the Sinopharm vaccine (Sars-CoV-2 Vero Cell,...

Indonesia Window

23 March 2022

COVID-19 – Indonesia issues EUA for Paxlovid as medicine
National

COVID-19 – Indonesia issues EUA for Paxlovid as medicine

"The recommended dose is 300 mg Nirmatrelvir (two 150 mg tablets) with 100 mg Ritonavir (one 100 mg tablet) taken together twice a day for five days." Jakarta (...

Indonesia Window

18 July 2022

COVID-19 – Indonesia approves Comirnaty for booster on children 16-18 yo
National

COVID-19 – Indonesia approves Comirnaty for booster on children 16-18 yo

A clinical study on children aged 16 years old and above (test subject C4591031 Sub A) showed an efficacy of 95.6 percent in preventing the occurrence of COVID-...

Indonesia Window

03 August 2022

Drugs from natural resources
National

Indonesia has great potentials in developing drugs from natural resources

“The COVID-19 pandemic has become a momentum in encouraging many research and development initiatives, both on drugs and vaccines, which aim to treat and preven...

Indonesia Window

26 August 2022

Qdenga dengue vaccine
National

Qdenga dengue vaccine for ages 6-45 allowed for distribution in Indonesia

The Qdenga dengue vaccine shows good efficacy in seropositive subjects (having antibodies to the Dengue virus) and seronegative subjects (not yet having antibod...

Indonesia Window

09 September 2022

Indovac and AWcorna vaccines
National

COVID-19 – Indonesia issues EUA for Indovac vaccine, AWcorna vaccine

Indovac and AWcorna vaccines have received Emergency Use Authorization (EUA) for the prevention of COVID-19 caused by SARS CoV-2 for individuals aged 18 years a...

Indonesia Window

30 September 2022

Etana Biotechnologies Indonesia
National

Indonesia inaugurates first mRNA-based COVID-19 vaccine factory in SE Asia

Etana Biotechnologies Indonesia is the first mRNA-based COVID-19 vaccine producer in Indonesia and Southeast Asia. Jakarta (Indonesia Window) – Indonesian Presi...

Indonesia Window

09 October 2022

drug syrups for children
National

Agency reaffirms drug syrups for children as informed by WHO

Jakarta (Indonesia Window) – Indonesia’s National Agency of Drug and Food Control (BPOM) has reaffirmed that the drug syrups for children mentioned in the infor...

Indonesia Window

20 October 2022

Denpasar Immigration Office
National

Denpasar Immigration Office deports Russian and Australian

Denpasar Immigration Office has deported two foreigners identified as SS (20) with a Russian nationality and JDA (47) with an Australian nationality, who have v...

Indonesia Window

15 March 2023

international seminar
National

Narcotics agency supports international seminar to create drug-free campuses

An international seminar carried a theme 'the role of academics in creating drug-free campuses and making people understand halal products through family resili...

Indonesia Window

05 July 2023

The herbal treatment clinic
National

Rochi’s herbal clinic treats patients with holistic therapy

The herbal treatment clinic of Tabib (healer) Rochi located in Indonesia’s Bogor city, West Java province, applies a holistic method in treating patients with v...

Indonesia Window

03 September 2024

12
Logo
Tentang KamiPrivasiHubungi Kami